Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 48 Leukemia 41 Breast Neoplasms 28 Lymphoma 21 Leukemia, Myeloid, Acute 16 Burkitt Lymphoma 13 Myelodysplastic Syndromes 11 Graft vs Host Disease 10 Lymphoma, Non-Hodgkin 7 Lymphoma, Large B-Cell, Diffuse 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Leukemia, Biphenotypic, Acute 7 Squamous Cell Carcinoma of Head and Neck 6 Urinary Bladder Neoplasms 5 Leukemia, Promyelocytic, Acute 5 Hodgkin Disease 5 Anemia, Refractory, with Excess of Blasts 5 Osteosarcoma 4 Myeloproliferative Disorders 4 Lymphoma, Follicular 4 Leukemia, Myelomonocytic, Chronic 4 Head and Neck Neoplasms 4 Arthritis, Rheumatoid 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large-Cell, Anaplastic 3 Leukemia, Myeloid, Chronic-Phase 3 Leukemia, Myeloid, Accelerated Phase 3 Leukemia, Lymphocytic, Chronic, B-Cell 3

Interventions

exemestane 4 Tamoxifen 3 Paclitaxel 3 Letrozole 3 Goserelin 3 Cyclophosphamide 3 pegfilgrastim 2 Radiotherapy 2 Pyridoxine 2 Leuprolide 2 Fluorouracil 2 Epirubicin 2 Capecitabine 2 Bevacizumab 2 Anastrozole 2 trastuzumab biosimilar HLX02 1 ribociclib 1 elacestrant 1 Zoledronic Acid 1 Trastuzumab 1 Taxes 1 Radiosurgery 1 Prochlorperazine 1 Palonosetron 1 PF-05280014 1 Ontruzant 1 Ogivri 1 Neoadjuvant Therapy 1 Mometasone Furoate 1 Methotrexate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Breast Neoplasms, Male × Methotrexate × Clear all

NCT00301925 2018-08-08

TACT2

Institute of Cancer Research, United Kingdom

Phase 3 Unknown

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon ⚡